Detailed Mechanism Funding and Narrative

Details for Mechanism ID: 18185
Country/Region: Caribbean Region
Year: 2016
Main Partner: Davis Memorial Hospital and Clinic
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Pediatric Care and Support (PDCS) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Testing: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 67
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 71
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 1,072
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 745
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 1,955
HTS_TST Service Delivery Point (Facility): Index testing 2017 300
HTS_TST Service Delivery Point (Facility): Other PITC 2017 1,655
HTS_TST Sum of Aggregated Age/Sex <15 2017 138
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 1,817
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 1,955
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 3
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 3
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 34
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 38
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 38
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 2
PMTCT_EID Sum of Infant Age disaggregates 2017 40
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 35
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 27
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 8
TB_SCREENDX Screen Result: Screened Positive for TB 2017 35
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 1,030
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 644
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 35
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 9
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 1,718
TX_CURR Aggregated Age/Sex: <15 Female 2017 35
TX_CURR Aggregated Age/Sex: <15 Male 2017 9
TX_CURR Aggregated Age/Sex: 15+ Female 2017 1,030
TX_CURR Aggregated Age/Sex: 15+ Male 2017 644
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 1,718
TX_CURR Sum of Aggregated Age/Sex <15 2017 44
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 1,674
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 1,718
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 2
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 2
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 171
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 147
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 322
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 322
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 1,546
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 1,160
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 29
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 29
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 559
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 543
TX_PVLS Numerator: Indication: Routine 2017 1,160
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 40
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 38
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 753
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 715
TX_PVLS_den Denominator: Indication: Routine 2017 1,546
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 8
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 7
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 72
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 64
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 151
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 178
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 10
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 8
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 84
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 76